Oxford University unit in Brazil will have two sites in downtown Rio de Janeiro

One of the reasons for choosing Rio de Janeiro was the partnership in the development of the Oxford/AstraZeneca vaccine, said Andrew Pollard, director of the Oxford Vaccine Group.

RIO DE JANEIRO, BRAZIL - The branch in Brazil will have two offices in Rio de Janeiro, said Andrew Pollard, director of the Oxford Vaccine Group in an interview with Globo.

The first, at the Carlos Chagas Institute, will be the team's base, for research and courses. Another headquarters, for projects carried out in partnership with the Ministry of Health, will be announced this Monday and will be located at the Cultural Center of the Ministry of Health, at Marechal Âncora square.

At Carlos Chagas, research will be carried out completely independent of the government, with funding from other financial . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?